Lentiviral human ITSN2 sgRNA gene knockout kit

Lentiviral human ITSN2 sgRNA gene knockout kit

Catalog Number:
CGKK542893FEN
Mfr. No.:
HKO-614417
Price:
$878
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Kit Components: Lentiviral particles or plasmids for a set of three sgRNAs, and a pair of Indel screening PCR primers

          sgRNA lentiviral particle information
          • Functional titer: 1x10^8 TU/ml
          • Titration method: counting puromycin resistant cell clones
          • Purity: In vivo grade
          • Pseudotype: VSVG
          • Storage buffer: LentiShield™ lentivirus storage buffer
          • Storage: condition -80°C
          • Availability: 3-5 weeks

          sgRNA lentiviral plasmid information
          • Promoter for target sgRNA: U6
          • Mammalian selection: puromycin
          • Promoter for mammalian selection gene: EF1a
          • E.coli selection: Amp
          • Storage condition: -20°C
          • Availability: 1-2 weeks

          Please contact us at for specific academic pricing.

          Target Information

          Target Name
          Human ITSN2
          About Target
          Gene symbol: ITSN2
          Synonyms: PRO2015 SH3D1B SH3P18 SWA SWAP
          Species: HUMAN
          Gene ID: 50618
          Summary: This gene encodes a cytoplasmic protein which contains SH3 domains. This protein is a member of a family of proteins involved in clathrin-mediated endocytosis. Intersectin 2 is thought to regulate the formation of clathrin-coated vesicles and also may function in the induction of T cell antigen receptor (TCR) endocytosis. [provided by RefSeq, Jan 2017].
          NM numbers targeted (Accession number:Exon:CDS Fragment): NM_006277:6:5 NM_147152:6:5 NM_019595:6:5 NM_001348181:7:4 NM_001348182:6:5 NM_001348183:6:5 NM_001348184:7:4 NM_001348185:6:5 NM_001348186:6:5
      • Properties
        • * For Research Use Only.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.